Telomerase activation in a model of lung adenocarcinoma

European Respiratory Journal

Volumn 27, Issue 6, 2006, Pages 1175-1182

  Suau, F ^a   Cottin, Vincent ^a,b   Archer, F ^a   Croze, S ^a   Chastang, J ^a   Cordier, G ^a   Thivolet Bejui F ^a,c   Mornex, J F ^a,b   Leroux, C ^a  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

Akt; Bronchioloalveolar carcinoma; Jaagsiekte sheep retrovirus; Lung cancer; Telomerase; Type II pneumocyte

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN KINASE B; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHEEP; SIGNAL TRANSDUCTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR CELL; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; CELL DIVISION; CELL TRANSFORMATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; JAAGSIEKTE SHEEP RETROVIRUS; LUNG; LUNG ALVEOLUS; LUNG TUMOR; PATHOLOGY; SHEEP DISEASE;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; CELL AGING; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; JAAGSIEKTE SHEEP RETROVIRUS; LUNG; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY ADENOMATOSIS, OVINE; PULMONARY ALVEOLI; SHEEP; SIGNAL TRANSDUCTION; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 33750696307     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00125105     Document Type: Article

References (37)

1. Wislez M, Massiani MA, Milleron B, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest 2003; 123: 1868-1877.
2. Travis WD, Brambilla E, Muller-Hemerlink HK, Harris CC. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, International Agency for Research on Cancer Press, 2004.
3. Mornex JF, Thivolet F, De las Heras M, Leroux C. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr Top Microbiol Immunol 2003; 275: 225-248.
4. Palmarini M, Sharp JM, de las Heras M, Fan H. Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep. J Virol 1999; 73: 6964-6972.
5. Wootton SK, Halbert CL, Miller AD. Sheep retrovirus structural protein induces lung tumours. Nature 2005; 434: 904-907.
6. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
7. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004; 113: 160-168.
8. Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436: 642.
9. Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer 2001; 1: 203-213.
10. Lee JC, Jong HS, Yoo CG, Han SK, Shim YS, Kim YW. Telomerase activity in lung cancer cell lines and tissues. Lung Cancer 1998; 21: 99-103.
11. Kang SS, Kwon T, Kwon DY, Do SI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999; 274: 13085-13090.
12. Shah A, Swain WA, Richardson D, et al. Phospho-Akt expression is associated with a favorable outcome in nonsmall cell lung cancer. Clin Cancer Res 2005; 11: 2930-2936.
13. Simsir A, Wei XJ, Yee H, Moreira A, Cangiarella J. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Am J Clin Pathol 2004; 121: 350-357.
14. Danilkovitch-Miagkova A, Duh FM, Kuzmin I, et al. Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc Natl Acad Sci USA 2003; 100: 4580-4585.
15. Maeda N, Fu W, Ortin A, de las Heras M, Fan H. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines. J Virol 2005; 79: 4440-4450.
16. Liu SL, Duh FM, Lerman MI, Miller AD. Role of virus receptor Hya12 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus Env proteins. J Virol 2003; 77: 2850-2858.
17. Onishi T, Nouso K, Higashi T, et al. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol 2003; 18: 1168-1174.
18. Fukushima M, Shimomura N, Nakamura K, et al. Demonstration of human telomerase reverse transcriptase by in situ hybridization in lung carcinoma. Oncol Rep 2004; 12: 1227-1232.
19. Lantuejoul S, Soria JC, Moro-Sibilot D, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 2004; 90: 1222-1229.
20. Lantuejoul S, Soria JC, Morat L, et al. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res 2005; 11: 2074-2082.
21. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3: 1271-1274.
22. Driscoll B, Buckley S, Bui KC, Anderson KD, Warburton D. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1191-L1198.
23. Sharma GG, Gupta A, Wang H, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003; 22: 131-146.
24. Rahman R, Latonen L, Wiman KG. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 2005; 24: 1320-1327.
25. Marchetti A, Bertacca G, Buttitta F, et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 1999; 5: 2077-2081.
26. Nakanishi K, Kawai T, Kumaki F, Hirot S, Mukai M, Ikeda E. Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung. Hum Pathol 2002; 33: 697-702.
27. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999; 21: 115-118.
28. Bellacosa A, Kumar CC, Di Cristofano, A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005; 94: 29-86.
29. Cheng JQ Altomare DA, Klein MA, et al, Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 1997; 14: 2793-2801.
30. Erman M, Grunenwald D, Penault-Llorca F, et al. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features. Lung Cancer 2005; 47: 315-323.
31. Maeda N, Palmarini M, Murgia C, Fan H. Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA. Proc Natl Acad Sci USA 2001; 98: 4449-4454.
32. Zavala G, Pretto C, Chow YH, et al. Relevance of Akt phosphorylation in cell transformation induced by Jaagsiekte sheep retrovirus. Virology 2003; 312: 95-105.
33. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
34. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-1500.
35. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004; 22: 1103-1109.
36. Yoshida Y, Shibata T, Kokubu A, et al, Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005; 50: 1-8.
37. Kokubo Y, Gemma A, Noro R, et al. Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA). Br J Cancer 2005; 92: 1711-1719.